Ameriprise’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.31M | Sell |
69,763
-3,216
| -4% | -$136K | ﹤0.01% | 2886 |
|
|
2025
Q4 | $3.38M | Sell |
72,979
-573
| -0.8% | -$24K | ﹤0.01% | 2716 |
|
|
2025
Q3 | $2.57M | Sell |
73,552
-3,073
| -4% | -$107K | ﹤0.01% | 2878 |
|
|
2025
Q2 | $2.27M | Sell |
76,625
-15,150
| -17% | -$432K | ﹤0.01% | 2882 |
|
|
2025
Q1 | $2.74M | Buy |
91,775
+1,148
| +1% | +$35.1K | ﹤0.01% | 2716 |
|
|
2024
Q4 | $2.6M | Sell |
90,627
-75,390
| -45% | -$2.49M | ﹤0.01% | 2777 |
|
|
2024
Q3 | $6.41M | Buy |
166,017
+60,026
| +57% | +$2.14M | ﹤0.01% | 2198 |
|
|
2024
Q2 | $3.41M | Buy |
105,991
+8,305
| +9% | +$288K | ﹤0.01% | 2576 |
|
|
2024
Q1 | $3.79M | Sell |
97,686
-3,655
| -4% | -$128K | ﹤0.01% | 2533 |
|
|
2023
Q4 | $3.12M | Sell |
101,341
-14,834
| -13% | -$372K | ﹤0.01% | 2643 |
|
|
2023
Q3 | $2.6M | Sell |
116,175
-10,506
| -8% | -$240K | ﹤0.01% | 2695 |
|
|
2023
Q2 | $2.72M | Sell |
126,681
-4,431
| -3% | -$101K | ﹤0.01% | 2724 |
|
|
2023
Q1 | $3.15M | Sell |
131,112
-3,861
| -3% | -$102K | ﹤0.01% | 2614 |
|
|
2022
Q4 | $3.13M | Sell |
134,973
-28,007
| -17% | -$565K | ﹤0.01% | 2579 |
|
|
2022
Q3 | $2.61M | Sell |
162,980
-101,395
| -38% | -$1.79M | ﹤0.01% | 2658 |
|
|
2022
Q2 | $4.68M | Sell |
264,375
-26,389
| -9% | -$444K | ﹤0.01% | 2332 |
|
|
2022
Q1 | $5.92M | Buy |
290,764
+21,878
| +8% | +$413K | ﹤0.01% | 2311 |
|
|
2021
Q4 | $5.02M | Buy |
268,886
+119,132
| +80% | +$2.32M | ﹤0.01% | 2459 |
|
|
2021
Q3 | $2.96M | Sell |
149,754
-11,575
| -7% | -$250K | ﹤0.01% | 2705 |
|
|
2021
Q2 | $3.81M | Sell |
161,329
-24,522
| -13% | -$566K | ﹤0.01% | 2633 |
|
|
2021
Q1 | $4.41M | Buy |
185,851
+118,044
| +174% | +$2.8M | ﹤0.01% | 2469 |
|
|
2020
Q4 | $1.36M | Sell |
67,807
-22,725
| -25% | -$444K | ﹤0.01% | 2948 |
|
|
2020
Q3 | $1.89M | Buy |
90,532
+2,881
| +3% | +$52K | ﹤0.01% | 2699 |
|
|
2020
Q2 | $1.53M | Buy |
87,651
+1,383
| +2% | +$27.1K | ﹤0.01% | 2731 |
|
|
2020
Q1 | $1.41M | Sell |
86,268
-6,545
| -7% | -$135K | ﹤0.01% | 2660 |
|
|
2019
Q4 | $1.91M | Buy |
92,813
+1,660
| +2% | +$27.7K | ﹤0.01% | 2755 |
|
|
2019
Q3 | $1.05M | Sell |
91,153
-18,715
| -17% | -$214K | ﹤0.01% | 3004 |
|
|
2019
Q2 | $1.45M | Buy |
+109,868
| New | +$1.47M | ﹤0.01% | 2913 |
|
|
2018
Q3 | – | Sell |
-8,830
| Closed | -$211K | – | 3731 |
|
|
2018
Q2 | $211K | Sell |
8,830
-46,282
| -84% | -$1.14M | ﹤0.01% | 3474 |
|
|
2018
Q1 | $1.41M | Buy |
+55,112
| New | +$1.31M | ﹤0.01% | 2829 |
|
|
2016
Q2 | – | Sell |
-75,865
| Closed | -$1.38M | – | 3784 |
|
|
2016
Q1 | $1.38M | Buy |
+75,865
| New | +$1.38M | ﹤0.01% | 2706 |
|
Other funds holding COLL
EAM
VCM
